LM PAY S.A. Reports Solid FY 2025 Performance and Positive Q1 2026 Business Momentum

LM PAY reported 2025 revenue of PLN 37.8m (+48.5% YoY) and EBIT up from PLN 7.0m to PLN 10.8m, indicating strong operating momentum. Despite a reported 2025 net loss of PLN -1.9m due to deferred tax timing effects and presentation/policy changes, underlying gross profit was PLN 1.2m. In Q1 2026, sales rose to PLN 7.5m (+3.8% YoY) while EBIT fell 24.6% to PLN 1.6m on higher development and insurance partner expansion costs; additionally, Romania expansion is suspended after NBR refused branch registration due to minority-shareholder documentation requirements.

Analysis

This is not a clean “growth up = buy” print; it is a reminder that embedded-finance economics are highly sensitive to funding partners, compliance, and the cadence of partner adds. The FY jump looks strong, but the sharper signal is that Q1 momentum slowed while spend rose, implying the next leg of growth is being bought with development and integration costs rather than purely harvested from the existing network.

The competitive winner here is the operator with the most trusted distribution and the cleanest licensing posture. That favors incumbents with bank-grade compliance and local balance sheets, while punishing smaller point-of-sale lenders that depend on wholesale funding or cross-border approvals. The Romania setback is important because it shows expansion can be blocked by governance/documentation friction long before unit demand becomes the issue; that pushes the relevant catalyst out from days to months.

For public comps, the read-through is to regulated consumer-finance platforms rather than regional banks, so NBHC is only a very indirect proxy. The contrarian angle is that the market may overvalue headline revenue growth and underweight cash conversion quality: if early repayment accounting and refinancing-partner changes are distorting the revenue line, the real question is whether core take-rate and cohort retention can stay intact once expansion spend normalizes. The near-term falsifier is any 2026 guide that implies further EBIT compression without a corresponding acceleration in partner-driven origination growth.

Key Decisions for Investors

• No direct NBHC trade on this release; treat the setup as non-actionable for a U.S. regional bank proxy unless there is a confirmed read-through to domestic consumer credit trends.
• Watch the audited FY2025 filing and July 7 guidance closely; if management confirms that EBIT margin is stabilizing despite expansion spend, the small-cap embedded-finance theme could be worth a selective long, but not before cash-flow visibility improves.
• Relative value idea: favor regulated, balance-sheet-backed consumer finance names over funding-dependent fintech lenders on any market strength; a pair like long SOFI / short UPST is the cleaner expression if risk appetite is positive.
• Set an alert for further regulatory setbacks in Central/Eastern Europe; a second licensing delay would falsify the expansion story and likely compress the multiple of similar microcap fintechs by 20-30% over 1-3 months.
• If the stock universe trades this as a generic fintech growth win, fade that move into the audit release unless Q2 confirms re-acceleration in revenue and no further margin dilution.